Contact Us
Center for Rare Disease Therapies535 Watson Drive
Claremont, CA 91711 Phone: (909) 607-0120
Email: CRDT
Center News
KGI Faculty to Co-Edit Journal of Rare Disorders
June 11, 2012
June 11, 2012
The world of rare disease research will get a new forum to exchange ideas and report discoveries thanks to the publication of a new e-journal to be titled "The Journal of Rare Disorders."
KGI Student Wins Federal Grant to Study Rare Insomnia Disorder
April 10, 2012
KGI student Kate Brown wins a grant from the Social Security Administration to help fast-track disability benefits to Fatal Familial Insomnia patients.
April 10, 2012
KGI student Kate Brown wins a grant from the Social Security Administration to help fast-track disability benefits to Fatal Familial Insomnia patients.
Professor Ian Phillips to Speak at Two National Conferences
February 27, 2012
Dr. Ian Phillips, Norris Professor of Life Sciences and Director of the Center for Rare Disease Therapies, is set to speak at two upcoming conferences this March: the Rare Disease Leader's Forum, in San Francisco and the Stem Cells for Drug Developers conference in Boston.
February 27, 2012
Dr. Ian Phillips, Norris Professor of Life Sciences and Director of the Center for Rare Disease Therapies, is set to speak at two upcoming conferences this March: the Rare Disease Leader's Forum, in San Francisco and the Stem Cells for Drug Developers conference in Boston.
New Team Masters Projects Include Emphasis on Rare Diseases
November 22, 2011
While this year's Team Masters Projects (TMPs) at KGI cover a wide spectrum of topics, four TMPs focus specifically on rare diseases, reflecting an increasing interest among pharmaceutical companies in exploring new business models for developing medicines to treat rare conditions—also known as "orphan drugs."
November 22, 2011
While this year's Team Masters Projects (TMPs) at KGI cover a wide spectrum of topics, four TMPs focus specifically on rare diseases, reflecting an increasing interest among pharmaceutical companies in exploring new business models for developing medicines to treat rare conditions—also known as "orphan drugs."
Professor Ian Phillips to lead Rare Disease Workshop in Boston
November 10, 2011
Professor Ian Phillips will lead a workshop on developing rare disease therapies at the 2nd World Orphan Drug Summit on November 15 in Boston, Massachusetts.
November 10, 2011
Professor Ian Phillips will lead a workshop on developing rare disease therapies at the 2nd World Orphan Drug Summit on November 15 in Boston, Massachusetts.
Workshop Leads to New Orphan Drug Opportunities
August 15, 2011
Thanks to a workshop co-sponsored by KGI's Center of Rare Disease Therapies, NATCO Pharma Ltd has become the first Indian company to receive approval from the U.S. Food and Drug Administration (FDA) for an Orphan Drug designation application.
August 15, 2011
Thanks to a workshop co-sponsored by KGI's Center of Rare Disease Therapies, NATCO Pharma Ltd has become the first Indian company to receive approval from the U.S. Food and Drug Administration (FDA) for an Orphan Drug designation application.
Prof. Phillips to Address Rare Disease Summit
July 7, 2011
Professor Ian Phillips, PhD, director of KGI's Center for Rare Disease Therapies, will talk about the unique role that academics can play in rare disease therapies at the 6th annual Rare Disease Leadership Summit in Washington, DC, July 12-13.
July 7, 2011
Professor Ian Phillips, PhD, director of KGI's Center for Rare Disease Therapies, will talk about the unique role that academics can play in rare disease therapies at the 6th annual Rare Disease Leadership Summit in Washington, DC, July 12-13.
Former FDA Official Tim Coté Joins KGI Faculty
June 15, 2011
Dr. Tim Coté, a former high-level official with the U.S. Food and Drug Administration (FDA), will join Keck Graduate Institute's faculty in July, bringing extensive knowledge and experience in clinical regulatory affairs.
June 15, 2011
Dr. Tim Coté, a former high-level official with the U.S. Food and Drug Administration (FDA), will join Keck Graduate Institute's faculty in July, bringing extensive knowledge and experience in clinical regulatory affairs.
Students Aid Search for Lymphomatic Malformation Cure
May 14, 2011
Three KGI premed students turned a classroom assignment into a successful effort that could eventually help save the lives of hundreds of small children suffering from lymphomatic malformation.
May 14, 2011
Three KGI premed students turned a classroom assignment into a successful effort that could eventually help save the lives of hundreds of small children suffering from lymphomatic malformation.
President Schuster Joins National Rare Disease Advocacy Board
March 31, 2011
KGI President Sheldon M. Schuster, PhD, has been elected to the National Organization for Rare Disorders (NORD) Board of Directors, joining other noted leaders in the rare disease community.
March 31, 2011
KGI President Sheldon M. Schuster, PhD, has been elected to the National Organization for Rare Disorders (NORD) Board of Directors, joining other noted leaders in the rare disease community.